Using Genetic Testing in Prostate Cancer: When and How
Alan H. Bryce, MD, delves into the critical role of genetic testing in prostate cancer management.
Read More
Alan H. Bryce
Putting Germline Testing into Context: A Primer and Current Knowledge
Alan H. Bryce, MD, explores the critical role of germline testing in prostate cancer, providing a primer on its current applications. He emphasizes identifying these genetic markers for patient management and familial risk assessment.
The 9-minute presentation considers the most relevant genes associated with prostate cancer risk, including BRCA1, BRCA2, and ATM. Dr. Bryce also highlights data problems with germline variants, questioning the representation of diverse racial and ethnic groups in clinical trials.
Read More
Panel Discussion: Didactic Session 7: Emerging Therapies
William K. Oh, MD; Alan H. Bryce, MD; Oliver Sartor, MD
Read More
Panel Discussion: Didactic Session 6: Advanced Disease
William K. Oh, MD; Alan H. Bryce, MD; Oliver Sartor, MD; Juanita M. Crook, MD, FRCPC; James A. Eastham, MD, FACS
Read More
Case Studies in Advanced Prostate Cancer
William K. Oh, MD; Alan H. Bryce, MD; Oliver Sartor, MD
Read More